Biocode Gastrointestinal Pathogen Panel (GPP)— 510(k) K190585

Name: FDA 510(k) clearance K190585
Creator: U.S. Food and Drug Administration
Published: 2019-06-05

Substantially Equivalent

Applied BioCode, Inc.

FDA 510(k) clearance K190585 for Biocode Gastrointestinal Pathogen Panel (GPP), Substantially Equivalent on 2019-06-05. Applicant: Applied BioCode, Inc.. Device class: 2.

Clearance details

Applicant: Applied BioCode, Inc.
Product code: Code PCH
Device class: Class 2
Regulation: 21 CFR 866.3990
Advisory panel: Microbiology
Date received: 2019-03-06
Decision date: 2019-06-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Santa Fe Springs, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code PCH

view all

K253722 — LIAISON PLEX Gastrointestinal Flex Assay2026-05-19
K254032 — QIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V2026-03-09
K251721 — Xpert GI Panel2026-01-16
K252329 — QIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V2025-10-22
K251868 — Panther Fusion GI Bacterial Assay2025-09-25

More clearances from Applied BioCode, Inc.

view all

K254139 — BioCode® Respiratory Pathogen Panel (RPP)2026-05-01
K242877 — BioCode Gastrointestinal Pathogen Panel (GPP)2025-01-10
K192485 — BioCode Respiratory Pathogen Panel (RPP)2019-12-23
K180041 — BioCode Gastrointestinal Pathogen Panel (GPP)2018-09-28

Data sourced from openFDA. This site is unofficial and independent of the FDA.